Clinical Trials Browser

EP-100 membrane-disrupting peptide × Clear all

NCT01485848 2014-06-10

ESP2011-002

Phase 2 Completed

Ovarian Cancer Recurrent

NCT00949559 2012-04-04

Pharmacodynamics (PD) and Pharmacokinetics (PK) Study of EP-100 in Advanced Solid Tumors

Phase 1 Completed

Other solid neoplasm

Solid Tumors